Virologist Robert G. Webster, Ph.D., of St. Jude Children’s Research Hospital, is the recipient of the Charles Mérieux Award from the National Foundation for Infectious Diseases (NFID). Webster accepted the award recently at the organization’s 16th Annual Conference on Vaccine Research.
The Charles Mérieux Award is given to those who have demonstrated a commitment to science-based medicine and research in infectious diseases, proven excellence in clinical and research activities, and shown dedication to improving public health.
Webster is internationally recognized as an expert in how new influenza strains evolve, credited with demonstrating the importance of aquatic birds as the reservoir for influenza and in aiding the development of better influenza vaccines and anti-viral drugs.
His work was instrumental in St. Jude being designated in 1975 as a World Health Organization (WHO) Collaborating Center for Studies on the Ecology of Influenza in Animals and Birds, of which he was the first director. The center at St. Jude — the only non-governmental organization among the current six centers — is focused on how the influenza virus mutates as it passes from birds to other animals and ultimately to humans and has surveillance sites around the globe to track the spread of new influenza strains.
St. Jude is currently producing seed stock for a potential vaccine against H7N9, the deadly new influenza currently affecting people in Asia.
Webster has received many honors, including election to the Royal Society, London; the Royal Society of New Zealand; and the U.S. National Academy of Sciences. In 2010, Webster presented the Leeuwenhoek Prize lecture, a prestigious recognition awarded by the Royal Society, London. He has also served as a consultant to the WHO, the National Institute of Allergy and Infectious Diseases, and holds the Rose Marie Thomas Chair in Infectious Diseases at St. Jude.
The NFID is a non-profit organization dedicated to educating the public and health care professionals about the causes, treatment and prevention of infectious diseases. The NFID award is named in honor of Charles Merieux, M.D., a French humanist and entrepreneur who devoted his life to infectious diseases prevention.
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer and other life-threatening diseases. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. St. Jude is ranked the No. 1 pediatric cancer hospital by U.S. News & World Report. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20 percent to 80 percent since the hospital opened more than 50 years ago. St. Jude freely shares the breakthroughs it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children. Families never receive a bill from St. Jude for treatment, travel, housing and food — because all a family should worry about is helping their child live. To learn more, visit stjude.org or follow St. Jude on social media at @stjuderesearch.